Co-expression of wild-type P2X7R with GLn460Arg variant alters receptor function

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Aprile Garcia, Fernando ^a,b   Metzger, Michael W ^c   Paez Pereda, Marcelo ^c   Stadler, Herbert ^d   Acuña, Matías ^a   Liberman, Ana C ^a   Senin, Sergio A ^a   Gerez, Juan ^a   Hoijman, Esteban ^b   Refojo, Damian ^c   Mitkovski, Mišo ^e   Panhuysen, Markus ^d   Stühmer, Walter ^e   Holsboer, Florian ^c,f   Deussing, Jan M ^c   Arzt, Eduardo ^a,b,c  

^a Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d Affectis Pharmaceutical AG   (Germany)

^e MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^f HMNC Brain Health   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; P2XR RECEPTOR, HUMAN; PURINERGIC P2X7 RECEPTOR; SMALL INTERFERING RNA;

FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETICS; HEK293 CELL LINE; HUMAN; IMMUNOPRECIPITATION; METABOLISM; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; WESTERN BLOTTING;

BLOTTING, WESTERN; CALCIUM; FLUORESCENCE RESONANCE ENERGY TRANSFER; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; PATCH-CLAMP TECHNIQUES; POLYMORPHISM, SINGLE NUCLEOTIDE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, PURINERGIC P2X7; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 85019363513     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0151862     Document Type: Article

References (61)

1. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature. 2006; 442(7102):527–32. PMID: 16885977
2. Jiang LH, Kim M, Spelta V, Bo X, Surprenant A, North RA. Subunit arrangement in P2X receptors. J Neurosci. 2003; 23(26):8903–10. PMID: 14523092
3. Antonio LS, Stewart AP, Xu XJ, Varanda WA, Murrell-Lagnado RD, Edwardson JM. P2X4 receptors interact with both P2X2 and P2X7 receptors in the form of homotrimers. British journal of pharmacology. 2011; 163(5):1069–77. Epub 2011/03/10. doi: 10.1111/j.1476-5381.2011.01303.x PMID: 21385174
4. Guo C, Masin M, Qureshi OS, Murrell-Lagnado RD. Evidence for functional P2X4/P2X7 heteromeric receptors. Molecular pharmacology. 2007; 72(6):1447–56. PMID: 17785580
5. Perez-Flores G, Levesque SA, Pacheco J, Vaca L, Lacroix S, Perez-Cornejo P, et al. The P2X7/P2X4 interaction shapes the purinergic response in murine macrophages. Biochemical and biophysical research communications. 2015; 467(3):484–90. Epub 2015/10/13. doi: 10.1016/j.bbrc.2015.10.025 PMID: 26456657
6. Nicke A. Homotrimeric complexes are the dominant assembly state of native P2X7 subunits. Biochemical and biophysical research communications. 2008; 377(3):803–8. doi: 10.1016/j.bbrc.2008.10.042 PMID: 18938136
7. Virginio C, MacKenzie A, North RA, Surprenant A. Kinetics of cell lysis, dye uptake and permeability changes in cells expressing the rat P2X7 receptor. J Physiol. 1999; 519 Pt 2:335–46. PMID: 10457053
8. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science. 1996; 272(5262):735–8. PMID: 8614837
9. Gendron FP, Neary JT, Theiss PM, Sun GY, Gonzalez FA, Weisman GA. Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am J Physiol Cell Physiol. 2003; 284(2):C571–81. PMID: 12529254
10. Panenka W, Jijon H, Herx LM, Armstrong JN, Feighan D, Wei T, et al. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase. J Neurosci. 2001; 21(18):7135–42. PMID: 11549724
11. Ferrari D, Chiozzi P, Falzoni S, Hanau S, Di Virgilio F. Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin. J Exp Med. 1997; 185(3):579–82. PMID: 9053458
12. Bulanova E, Budagian V, Orinska Z, Hein M, Petersen F, Thon L, et al. Extracellular ATP induces cytokine expression and apoptosis through P2X7 receptor in murine mast cells. J Immunol. 2005; 174 (7):3880–90. PMID: 15778342
13. Shieh CH, Heinrich A, Serchov T, van Calker D, Biber K. P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-alpha in cultured mouse microglia. Glia. 2014; 62(4):592–607. Epub 2014/01/29. doi: 10.1002/glia.22628 PMID: 24470356
14. Wiley JS, Sluyter R, Gu BJ, Stokes L, Fuller SJ. The human P2X7 receptor and its role in innate immunity. Tissue antigens. 2011; 78(5):321–32. Epub 2011/10/13. doi: 10.1111/j.1399-0039.2011.01780.x PMID: 21988719
15. Barbera-Cremades M, Baroja-Mazo A, Gomez AI, Machado F, Di Virgilio F, Pelegrin P. P2X7 receptor-stimulation causes fever via PGE2 and IL-1beta release. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2012; 26(7):2951–62. Epub 2012/04/12.
16. Bartlett R, Yerbury JJ, Sluyter R. P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia. Mediators of inflammation. 2013; 2013:271813. Epub 2013/ 02/23. doi: 10.1155/2013/271813 PMID: 23431238
17. Sperlagh B, Illes P. P2X7 receptor: an emerging target in central nervous system diseases. Trends in pharmacological sciences. 2014; 35(10):537–47. Epub 2014/09/17. doi: 10.1016/j.tips.2014.08.002 PMID: 25223574
18. Bartlett R, Stokes L, Sluyter R. The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease. Pharmacological reviews. 2014; 66(3):638–75. Epub 2014/06/15. doi: 10.1124/pr.113.008003 PMID: 24928329
19. Deuchars SA, Atkinson L, Brooke RE, Musa H, Milligan CJ, Batten TF, et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems. J Neurosci. 2001; 21(18):7143–52. Epub 2001/09/11. PMID: 11549725
20. Gendron FP, Chalimoniuk M, Strosznajder J, Shen S, Gonzalez FA, Weisman GA, et al. P2X7 nucleotide receptor activation enhances IFN gamma-induced type II nitric oxide synthase activity in BV-2 microglial cells. J Neurochem. 2003; 87(2):344–52. Epub 2003/09/27. PMID: 14511112
21. Kataoka A, Tozaki-Saitoh H, Koga Y, Tsuda M, Inoue K. Activation of P2X7 receptors induces CCL3 production in microglial cells through transcription factor NFAT. J Neurochem. 2009; 108(1):115–25. doi: 10.1111/j.1471-4159.2008.05744.x PMID: 19014371
22. Murakami K, Nakamura Y, Yoneda Y. Potentiation by ATP of lipopolysaccharide-stimulated nitric oxide production in cultured astrocytes. Neuroscience. 2003; 117(1):37–42. Epub 2003/02/28. PMID: 12605890
23. Mingam R, De Smedt V, Amedee T, Bluthe RM, Kelley KW, Dantzer R, et al. In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1 beta in the murine brain. Brain, behavior, and immunity. 2008; 22(2):234–44. Epub 2007/10/02. PMID: 17905568
24. Monif M, Reid CA, Powell KL, Smart ML, Williams DA. The P2X7 receptor drives microglial activation and proliferation: a trophic role for P2X7R pore. J Neurosci. 2009; 29(12):3781–91. Epub 2009/03/27. doi: 10.1523/JNEUROSCI.5512-08.2009 PMID: 19321774
25. Cabrini G, Falzoni S, Forchap SL, Pellegatti P, Balboni A, Agostini P, et al. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes. J Immunol. 2005; 175(1):82–9. PMID: 15972634
26. Ohlendorff SD, Tofteng CL, Jensen JE, Petersen S, Civitelli R, Fenger M, et al. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet Genomics. 2007; 17(7):555–67. Epub 2007/06/15. PMID: 17558311
27. Saunders BM, Fernando SL, Sluyter R, Britton WJ, Wiley JS. A loss-of-function polymorphism in the human P2X7 receptor abolishes ATP-mediated killing of mycobacteria. J Immunol. 2003; 171 (10):5442–6. Epub 2003/11/11. PMID: 14607949
28. Wiley JS, Dao-Ung LP, Li C, Shemon AN, Gu BJ, Smart ML, et al. An Ile-568 to Asn polymorphism prevents normal trafficking and function of the human P2X7 receptor. The Journal of biological chemistry. 2003; 278(19):17108–13. PMID: 12586825
29. Gu BJ, Sluyter R, Skarratt KK, Shemon AN, Dao-Ung LP, Fuller SJ, et al. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor. The Journal of biological chemistry. 2004; 279(30):31287–95. PMID: 15123679
30. Suadicani SO, Iglesias R, Spray DC, Scemes E. Point mutation in the mouse P2X7 receptor affects intercellular calcium waves in astrocytes. ASN neuro. 2009; 1(1). Epub 2009/07/03.
31. Gu BJ, Zhang W, Worthington RA, Sluyter R, Dao-Ung P, Petrou S, et al. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor. The Journal of biological chemistry. 2001; 276(14):11135–42. PMID: 11150303
32. Barden N, Harvey M, Gagne B, Shink E, Tremblay M, Raymond C, et al. Analysis of single nucleotide polymorphisms in genes in the chromosome 12Q24.31 region points to P2RX7 as a susceptibility gene to bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet. 2006; 141B(4):374–82. PMID: 16673375
33. Hejjas K, Szekely A, Domotor E, Halmai Z, Balogh G, Schilling B, et al. Association between depression and the Gln460Arg polymorphism of P2RX7 gene: a dimensional approach. Am J Med Genet B Neuropsychiatr Genet. 2009; 150B(2):295–9. doi: 10.1002/ajmg.b.30799 PMID: 18543274
34. Lucae S, Salyakina D, Barden N, Harvey M, Gagne B, Labbe M, et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet. 2006; 15(16):2438–45. PMID: 16822851
35. McQuillin A, Bass NJ, Choudhury K, Puri V, Kosmin M, Lawrence J, et al. Case-control studies show that a non-conservative amino-acid change from a glutamine to arginine in the P2RX7 purinergic receptor protein is associated with both bipolar- and unipolar-affective disorders. Mol Psychiatry. 2009; 14 (6):614–20. doi: 10.1038/mp.2008.6 PMID: 18268501
36. Soronen P, Mantere O, Melartin T, Suominen K, Vuorilehto M, Rytsala H, et al. P2RX7 gene is associated consistently with mood disorders and predicts clinical outcome in three clinical cohorts. Am J Med Genet B Neuropsychiatr Genet. 2011; 156B(4):435–47. Epub 2011/03/26. doi: 10.1002/ajmg.b.31179 PMID: 21438144
37. Nagy G, Ronai Z, Somogyi A, Sasvari-Szekely M, Rahman OA, Mate A, et al. P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients. Progress in neuro-psychopharmacology & biological psychiatry. 2008; 32(8):1884–8. Epub 2008/09/20.
38. Green EK, Grozeva D, Raybould R, Elvidge G, Macgregor S, Craig I, et al. P2RX7: A bipolar and unipolar disorder candidate susceptibility gene? Am J Med Genet B Neuropsychiatr Genet. 2009; 150B (8):1063–9. Epub 2009/01/23. doi: 10.1002/ajmg.b.30931 PMID: 19160446
39. Viikki M, Kampman O, Anttila S, Illi A, Setala-Soikkeli E, Huuhka M, et al. P2RX7 polymorphisms Gln460Arg and His155Tyr are not associated with major depressive disorder or remission after SSRI or ECT. Neuroscience letters. 2011; 493(3):127–30. Epub 2011/02/22. doi: 10.1016/j.neulet.2011.02.023 PMID: 21335057
40. Grigoroiu-Serbanescu M, Herms S, Muhleisen TW, Georgi A, Diaconu CC, Strohmaier J, et al. Variation in P2RX7 candidate gene (rs2230912) is not associated with bipolar I disorder and unipolar major depression in four European samples. Am J Med Genet B Neuropsychiatr Genet. 2009; 150B(7):1017–21. Epub 2009/03/31. doi: 10.1002/ajmg.b.30952 PMID: 19330776
41. Halmai Z, Dome P, Vereczkei A, Abdul-Rahman O, Szekely A, Gonda X, et al. Associations between depression severity and purinergic receptor P2RX7 gene polymorphisms. Journal of affective disorders. 2013; 150(1):104–9. Epub 2013/04/23. doi: 10.1016/j.jad.2013.02.033 PMID: 23602648
42. Roger S, Mei ZZ, Baldwin JM, Dong L, Bradley H, Baldwin SA, et al. Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions. J Psychiatr Res. 2010; 44(6):347–55. Epub 2009/11/26. doi: 10.1016/j.jpsychires.2009.10.005 PMID: 19931869
43. Feige JN, Sage D, Wahli W, Desvergne B, Gelman L. PixFRET, an ImageJ plug-in for FRET calculation that can accommodate variations in spectral bleed-throughs. Microsc Res Tech. 2005; 68(1):51–8. Epub 2005/10/07. PMID: 16208719
44. Xia Z, Liu Y. Reliable and global measurement of fluorescence resonance energy transfer using fluorescence microscopes. Biophys J. 2001; 81(4):2395–402. Epub 2001/09/22. PMID: 11566809
45. Young MT, Fisher JA, Fountain SJ, Ford RC, North RA, Khakh BS. Molecular shape, architecture, and size of P2X4 receptors determined using fluorescence resonance energy transfer and electron microscopy. The Journal of biological chemistry. 2008; 283(38):26241–51. Epub 2008/07/19. doi: 10.1074/ jbc.M804458200 PMID: 18635539
46. Costa-Junior HM, Sarmento Vieira F, Coutinho-Silva R. C terminus of the P2X7 receptor: treasure hunting. Purinergic signalling. 2011; 7(1):7–19. Epub 2011/04/13. doi: 10.1007/s11302-011-9215-1 PMID: 21484094
47. Feng YH, Li X, Wang L, Zhou L, Gorodeski GI. A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization. The Journal of biological chemistry. 2006; 281(25):17228–37. PMID: 16624800
48. Marquez-Klaka B, Rettinger J, Nicke A. Inter-subunit disulfide cross-linking in homomeric and heteromeric P2X receptors. Eur Biophys J. 2009; 38(3):329–38. doi: 10.1007/s00249-008-0325-9 PMID: 18427801
49. Burnstock G. Purinergic signalling and disorders of the central nervous system. Nat Rev Drug Discov. 2008; 7(7):575–90. doi: 10.1038/nrd2605 PMID: 18591979
50. Lodge NJ, Li YW. Ion channels as potential targets for the treatment of depression. Curr Opin Drug Discov Devel. 2008; 11(5):633–41. PMID: 18729015
51. Skaper SD, Debetto P, Giusti P. The P2X7 purinergic receptor: from physiology to neurological disorders. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2010; 24(2):337–45. Epub 2009/10/09.
52. Sperlagh B, Vizi ES, Wirkner K, Illes P. P2X7 receptors in the nervous system. Prog Neurobiol. 2006; 78(6):327–46. PMID: 16697102
53. Wong ML, Dong C, Maestre-Mesa J, Licinio J. Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response. Mol Psychiatry. 2008; 13 (8):800–12. doi: 10.1038/mp.2008.59 PMID: 18504423
54. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nature reviews Neuroscience. 2008; 9 (1):46–56. Epub 2007/12/13. PMID: 18073775
55. Jones KA, Thomsen C. The role of the innate immune system in psychiatric disorders. Molecular and cellular neurosciences. 2013; 53:52–62. Epub 2012/10/16. doi: 10.1016/j.mcn.2012.10.002 PMID: 23064447
56. Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets. 2007; 6(3):219–33. PMID: 17511618
57. Seifert G, Schilling K, Steinhauser C. Astrocyte dysfunction in neurological disorders: a molecular perspective. Nature reviews Neuroscience. 2006; 7(3):194–206. Epub 2006/02/24. PMID: 16495941
58. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. The American journal of psychiatry. 2000; 157(5):683–94. Epub 2000/04/28. PMID: 10784457
59. Hiles SA, Baker AL, de Malmanche T, Attia J. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain, behavior, and immunity. 2012; 26(7):1180–8. Epub 2012/06/13. doi: 10.1016/j.bbi.2012.06.001 PMID: 22687336
60. Liu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. Journal of affective disorders. 2012; 139(3):230–9. Epub 2011/08/30. doi: 10.1016/j. jad.2011.08.003 PMID: 21872339
61. Sluyter R, Stokes L. Significance of P2X7 receptor variants to human health and disease. Recent patents on DNA & gene sequences. 2011; 5(1):41–54. Epub 2011/02/10.